Howden C W, Forrest J A, Reid J L
Gut. 1984 Jul;25(7):707-10. doi: 10.1136/gut.25.7.707.
The effects of omeprazole, a substituted benzimidazole, on gastric acid and pepsin secretion have been studied in twelve healthy subjects. From six to eight hours after a single oral dose of 30 mg, there was a 66% reduction in basal acid output, and a 71.2% reduction in pentagastrin stimulated acid output. A single dose of 60 mg produced a 91.7% reduction in basal acid output and a 95.3% reduction in pentagastrin stimulated acid output. After seven days treatment with 30 or 60 mg daily, there was almost 100% inhibition of both basal and pentagastrin stimulated acid output. Omeprazole did not significantly affect pepsin secretion which is in keeping with its proposed mode of action, as an inhibitor of the H+/K+-ATPase enzyme on the secretory membrane of the parietal cell. There were no side effects after omeprazole either with single or repeated dosing.
在12名健康受试者中研究了一种取代苯并咪唑类药物奥美拉唑对胃酸和胃蛋白酶分泌的影响。单次口服30毫克后6至8小时,基础酸排出量降低了66%,五肽胃泌素刺激的酸排出量降低了71.2%。单次服用60毫克可使基础酸排出量降低91.7%,五肽胃泌素刺激的酸排出量降低95.3%。每日服用30毫克或60毫克,治疗7天后,基础酸排出量和五肽胃泌素刺激的酸排出量几乎均受到100%抑制。奥美拉唑对胃蛋白酶分泌无显著影响,这与其作为壁细胞分泌膜上H+/K+-ATP酶抑制剂的作用模式相符。奥美拉唑单次或重复给药后均无副作用。